5 May 2025 Date | | - Cons. EPS | - EPS |
31 Mar 2025 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
12 Aug 2024 Date | | - Cons. EPS | - EPS |
7 May 2024 Date | | - Cons. EPS | - EPS |
5 May 2025 Date | | - Cons. EPS | - EPS |
31 Mar 2025 Date | | - Cons. EPS | - EPS |
12 Nov 2024 Date | | - Cons. EPS | - EPS |
12 Aug 2024 Date | | - Cons. EPS | - EPS |
7 May 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Joshua Nathaniel Rosen CEO | CNSX Exchange | CA38238W1032 ISIN |
US Country | 385 Employees | - Last Dividend | - Last Split | - IPO Date |
Goodness Growth Holdings, Inc., operating within the United States, is a foremost cannabis company that engages in the cultivation, manufacturing, processing, and distribution of medical and adult-use cannabis products. Formerly known as Vireo Health International Inc., the company underwent a name change to Goodness Growth Holdings, Inc. in June 2021, marking a new chapter in its business evolution. The company's operational reach extends across Maryland, Minnesota, and New York, where it sells its products through Green Goods and other Goodness Growth branded retail dispensaries as well as third-party dispensaries. With its headquarters in Minneapolis, Minnesota, Goodness Growth Holdings, Inc. is at the forefront of providing regulated cannabis products to a growing market under stringent quality and compliance standards.